100 related articles for article (PubMed ID: 1803622)
1. Abnormal plasminogen Maywood I.
Robbins KC; Boreisha IG; Godwin JE
Thromb Haemost; 1991 Nov; 66(5):575-80. PubMed ID: 1803622
[TBL] [Abstract][Full Text] [Related]
2. The isolation and characterization of a ternary human plasmin B-chain-streptokinase-plasminogen complex.
Summaria L; Boreisha I; Barlow GH; Robbins KC
Thromb Haemost; 1987 Aug; 58(2):772-7. PubMed ID: 2960030
[TBL] [Abstract][Full Text] [Related]
3. Investigation of a congenital abnormal plasminogen, Frankfurt I, and its relationship to thrombosis.
Scharrer IM; Wohl RC; Hach V; Sinio L; Boreisha I; Robbins KC
Thromb Haemost; 1986 Jun; 55(3):396-401. PubMed ID: 2944241
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the esterase and human plasminogen activator activities of various activated forms of human plasminogen and their equimolar streptokinase complexes.
Wohl RC; Arzadon L; Summaria L; Robbins KC
J Biol Chem; 1977 Feb; 252(4):1141-7. PubMed ID: 851483
[TBL] [Abstract][Full Text] [Related]
5. Function of the central domain of streptokinase in substrate plasminogen docking and processing revealed by site-directed mutagenesis.
Chaudhary A; Vasudha S; Rajagopal K; Komath SS; Garg N; Yadav M; Mande SC; Sahni G
Protein Sci; 1999 Dec; 8(12):2791-805. PubMed ID: 10631997
[TBL] [Abstract][Full Text] [Related]
6. Role of the amino-terminal region of streptokinase in the generation of a fully functional plasminogen activator complex probed with synthetic peptides.
Nihalani D; Kumar R; Rajagopal K; Sahni G
Protein Sci; 1998 Mar; 7(3):637-48. PubMed ID: 9541396
[TBL] [Abstract][Full Text] [Related]
7. Isolation of a human plasmin-derived, functionally active, light (B) chain capable of forming with streptokinase an equimolar light (B) chain-streptokinase complex with plasminogen activator activity.
Summaria L; Robbins KC
J Biol Chem; 1976 Sep; 251(18):5810-13. PubMed ID: 134997
[TBL] [Abstract][Full Text] [Related]
8. In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses.
Summaria L; Sandesara J; Yang G; Vagher JP; Caprini JA
Thromb Haemost; 1986 Aug; 56(1):71-9. PubMed ID: 2946093
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of a stimulator of plasmin generation from the antiangiogenic agent Neovastat: identification as immunoglobulin kappa light chain.
Boivin D; Provençal M; Gendron S; Ratel D; Demeule M; Gingras D; Béliveau R
Arch Biochem Biophys; 2004 Nov; 431(2):197-206. PubMed ID: 15488468
[TBL] [Abstract][Full Text] [Related]
10. alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
Kluft C; Nieuwenhuis HK; Rijken DC; Groeneveld E; Wijngaards G; van Berkel W; Dooijewaard G; Sixma JJ
J Clin Invest; 1987 Nov; 80(5):1391-400. PubMed ID: 2445779
[TBL] [Abstract][Full Text] [Related]
11. Mapping of the plasminogen binding site of streptokinase with short synthetic peptides.
Nihalani D; Raghava GP; Sahni G
Protein Sci; 1997 Jun; 6(6):1284-92. PubMed ID: 9194188
[TBL] [Abstract][Full Text] [Related]
12. An anti-plasminogen antibody preparation that inhibits the activation of human plasminogen but enhances the activator activity of the B-chain-streptokinase complex.
Summaria L; Pavlovic B; Sandesara J
Thromb Res; 1989 Apr; 54(1):1-15. PubMed ID: 2727955
[TBL] [Abstract][Full Text] [Related]
13. Effect of fibrin-like stimulators on the activation of plasminogen by tissue-type plasminogen activator (t-PA)--studies with active site mutagenized plasminogen and plasmin resistant t-PA.
Lijnen HR; Van Hoef B; De Cock F; Collen D
Thromb Haemost; 1990 Aug; 64(1):61-8. PubMed ID: 2148848
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
Liu JN; Gurewich V
J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
[TBL] [Abstract][Full Text] [Related]
15. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD
Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080
[TBL] [Abstract][Full Text] [Related]
16. Kinetic properties of the activator complexes plasmin--staphylokinase and plasmin(ogen)--streptokinase in vitro.
Sazonova IY; Aisina RB; Muhametova LI; Varfolomeyev SD
Biochemistry (Mosc); 1999 Jan; 64(1):66-74. PubMed ID: 9986915
[TBL] [Abstract][Full Text] [Related]
17. Comparative activation kinetics of mammalian plasminogens.
Wohl RC; Sinio L; Summaria L; Robbins KC
Biochim Biophys Acta; 1983 May; 745(1):20-31. PubMed ID: 6682680
[TBL] [Abstract][Full Text] [Related]
18. The activation of two isozymes of glu-plasminogen (I and II) by urokinase and streptokinase.
Takada A; Takada Y
Thromb Res; 1983 Jun; 30(6):633-42. PubMed ID: 6351345
[TBL] [Abstract][Full Text] [Related]
19. Isoelectric focusing pattern of plasminogen mutants of patients with hypoplasminogenemia: correlation of in-vitro data with computer-predicted isoelectric points (pI).
Tefs K; Ott-Gueorguieva M; Kobelt L; Ziegler M; Hintze C; Hügle B; Schuster V
Blood Coagul Fibrinolysis; 2011 Sep; 22(6):499-505. PubMed ID: 21537161
[TBL] [Abstract][Full Text] [Related]
20. Activation of human plasminogen by equimolar levels of streptokinase.
Bajaj AP; Castellino FJ
J Biol Chem; 1977 Jan; 252(2):492-8. PubMed ID: 137901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
